| 发明名称 | Treatment of osteoarthritis pain | ||
| 摘要 | This invention discloses a method of treatment of osteoarthritis pain by administration of a histamine H3 receptor antagonist, described herein, a salt thereof, or a composition comprising such compound or salt. | ||
| 申请公布号 | US9186353(B2) | 申请公布日期 | 2015.11.17 |
| 申请号 | US201012767608 | 申请日期 | 2010.04.26 |
| 申请人 | AbbVie Inc. | 发明人 | Cowart Marlon D.;Hsieh Gin C.;Brioni Jorge D.;Sullivan James P. |
| 分类号 | A61K31/55;A61K31/425;A61K31/454;A61K31/501;A61K31/551;A61K31/517;A61K31/4375;A61K31/40;A61K31/497;A61K31/445;A61K31/428;A61K31/395;A61K31/41 | 主分类号 | A61K31/55 |
| 代理机构 | Michael Best & Friedrich LLP | 代理人 | Mueller Lisa V.;Michael Best & Friedrich LLP |
| 主权项 | 1. A method of treatment of osteoarthritis pain comprising administration of a histamine H3 receptor antagonist, a salt thereof, or a composition comprising such histamine H3 receptor antagonist or salt, to a mammal in need of treatment thereof, wherein the histamine H3 receptor antagonist is 2-[4-((1S,2S)-2-{[(2S)-2-methylpyrrolidin-1-yl]methyl}cyclopropyl)phenyl]pyridazin-3(2H) one. | ||
| 地址 | North Chicago IL US | ||